Dietary Management |
|
Ernährung und Allergie |
|
Allergen Data Collection:
Cow's Milk (Bos domesticus) ...................................................... |
||
Authors in alphabetical order [contact
information]
|
Abstract
Cow's milk allergy (CMA) can be defined as any adverse reaction mediated
by immunological mechanisms to cow's milk proteins. CMA can be divided
in IgE-mediated reactions (IgE-CMA) and non-IgE-mediated reactions (non-IgE-CMA)
which may involve other immunoglobulins, immune complexes and cell-mediated
reactions. Patients with non-IgE-CMA and digestive symptoms can present
with the following well defined clinical pictures: milk- induced enterocolitis,
milk- induced proctitis, or milk- induced enteropathy. CMA should be differentiated
from cow's milk intolerance (CMI) reactions due to lactase deficiency or
other non immune mediated causes which are not subject of the present review.
Most CMA has its onset in the first year of life, and becomes apparent
at the time of weaning from breastfeeding.
Prevalences of CMA range from 1.6% to 2.8% in unselected children younger
than 2 years of age (elimination / challenge proven). Oral tolerance is
frequently acquired in about 50 to 90% of children with CMA within the
first 6 years of life. However, severe CMA may persist into adulthood.
The frequency of sensitization to cow's milk in adults has recently been
estimated by RAST to be 0.7% and 1.2% in Scandinavian countries.
According to the onset of symptoms after milk ingestion CMA can be classified
as immediate or delayed- type. The clinical picture can vary from mild
to severe, involving the skin (eczema, hives, angioedema), gastrointestinal
tract (oral pruritis, colic, vomiting, diarrhea, constipation), respiratory
tract (cough, stridor, wheezing), and cardiovascular system (anaphylactic
shock).
No single laboratory test is diagnostic of CMA. Clinical manifestations
supported by skin tests and in vitro parameters are valuable. The diagnosis
is confirmed by well-defined elimination and subsequent challenge procedures.
If there is evidence of anaphylaxis, challenge should be avoided. The inadvertent
ingestion of small amounts of cow's milk allergens hidden in foods can
result in severe life- threatening clinical reactions. Cow's milk allergens
could be present in breast milk, infant formulas, milk and milk products
like cheese and yoghurt, as well as in "non-dairy" foods occurring as contaminants
or unlabeled additives. The most effective treatment of CMA is allergen
avoidance. Besides the optimal choice of breast milk, suitable milk substitutes
in the nutrition of infants with CMA are soy hydrolyzed formulas, extensively
casein and whey hydrolyzed formulas, and amino acid formulas. The exact
frequency of sensitization to soy protein in children with CMA is still
controversial. Soy allergy seems to be rare in IgE-CMA, while approximately
60% of children with milk- induced enterocolitis are sensitive to soybean.
Due to clinically important residual allergenicity in some hypoallergenic
formulas controlled clinical testing is necessary in each cow's milk sensitive
infant before use. Due to the high homology of protein composition sheep's
and goat's milk are cross-reactive in approximately 80% of subjects with
CMA.
In infants and children the major cow's milk allergens are casein (CAS),
beta- lactoglobulin (beta-LG), and alpha- lactalbumin (alpha-LA). Caseins
(alpha-, beta-, kappa-CAS) are the most important in children and adults.
Other allergens involved in CMA are bovine serum albumin (BSA) and bovine
immunoglobulins. Several IgE- binding epitopes of alpha-LA, beta-LG, alpha-
and beta-CAS have been described.
The present data collection summarizes the following topics in tabular
form: prevalences of CMA, diagnostic and therapeutic features, molecular
biological and allergenic properties of cow's milk allergens, stability
and hidden presence of allergens, the use of infant formulas in therapy
and prevention of CMA and other atopic diseases.
Disclaimer
The reference lists of the Allergen Data Collections
are based mainly on searches of Medline and FSTA (Food Science & Technology
Abstracts) databases up to the related dates of publication. The scientific
rigor of the studies listed is variable and not subject of critique or
evaluation by the authors or the editor of the Allergen Data Collections.
The reader should be aware of considerable problems in comparing data from
different studies (eg. patient cohorts, diagnostic performances, possible
flaws in allergen preparations and methodologies for allergen characterization)
and is encouraged to review the original publications.
The information provided by the Internet Symposium on
Food Allergens is for educational, communication and information purposes
only and is not intended to replace or constitute medical advice or treatments.
Neither the authors nor the editorial board of the Internet Symposium on
Food Allergens is responsible for the use which might be made of the information.
home: www.food-allergens.de |